Complications of radiotherapy in patients with age-related macular degeneration (AMD). A study of 48 cases;Complications de la radiotherapie des neovaissaux de la degenerescence maculaire liee a l'age. A propos d'une serie de 48 cas

Journal Francais d'Ophtalmologie

Volumn 23, Issue 2, 2000, Pages 151-157

  Valanconny, C ^a   Koenig, F ^a   Benchaboune, M ^a   Goyet, D ^a   Mezmate, K ^a   Schmitt, T ^a   Maugery, J ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

Age related macular degeneration; Complications; Radiation optic neuropathy; Radiation retinopathy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CLINICAL ARTICLE; ELECTRON BEAM; FEMALE; HUMAN; MALE; OPTIC NERVE DISEASE; RADIATION DOSE; RADIATION INJURY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINOPATHY; TREATMENT OUTCOME; ELECTRON; EYE; FOLLOW UP; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; NEOVASCULAR GLAUCOMA; RADIATION EXPOSURE; RETINA DISEASE; REVIEW; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ELECTRONS; EYE; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, NEOVASCULAR; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; RADIATION INJURIES; RADIOTHERAPY, HIGH-ENERGY; RETINAL DISEASES; VISUAL ACUITY;

EID: 0034065962     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ganley J, Roberts J. Eye condition and related need for medical care amoung persons 1-74 years of age. United States, 1971-1972. Vital and health statistics, series 11, 228, DHHS Publication No(PH5) 83-1678. Washington DC: GPO, 1983.
2. Kahn HA, Morhead HB. Statistics on blindness in the model reporting area, 1969-1970. DHEW publication No(NIH), 73-427.
3. Sorsby A. The incidence and causes of blindness in England and Wales 1948-1962. Reports in public health and medical subjects, no114 (London), Her Majesty's Stationery Office, 1966.
4. Ishibashi T, Patterson R, Onishi Y, Inomata H, Ryan SJ. Formation of drusen in the human eye. Am. J. Ophthalmol. 1986; 101: 342-53.
5. Leibowitz H, Krueger DE, Maunder LR, Milton R, Kini MM, Kagn HA, Micherson RJ, Pool J, Colton T, Ganley JP. The Framingham eye study monograph. Surv. Ophthalmol. 1980; 24(Suppl): 335-610.
6. Hirvelä H, Luukinen H, Läärä E, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmol. 1996; 103: 871-7.
7. Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration: results of a randomized clinical trial. Arch. Ophthalmol. 1991; 109: 1258-65.
8. Ferris FL III, Fine SL, Hyman LA. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol. 1984; 102: 1640-2.
9. Macular Photocoagulation Study Group. Argon Laser Photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch. Ophthalmol. 1982; 100: 912-8.
10. Yannuzzi LA. A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch. Ophthalmol. 1994; 112: 462-4.
11. Amoaku WMK, Frew L, Mahon GJ, Gardiner TA, Archer DB. Early ultrastructural changes after low-dose X-irradiation in the retina of the rat. Eye. 1989; 3: 638-46.
12. Amoaku WMK, Mahon GJ, Gardiner TA, Frew L, Archer DB. Late ultrastructural changes in the retina of the rat following low-dose X-irradiation. Graefe's Arch. Clin. Exp. Opthalmol. 1992; 230: 569-74.
13. Chakravarthy U, Biggart JH, Gardiner TA, Archer DB, Maguire CJF. Focal irradiation of perforating eye injuries: minimum effective dose and optimum time of irradiation. Curr. Eye Res. 1989; 8: 1241-50.
14. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related neovascular membranes by teletherapy: a pilot study. Br. J. Ophthalmol. 1993; 77: 265-73.
15. Bergink GJ, Deutman AF, Van Den Broek JFCM, Van Daal WAJ, Van Der Maazen RWN. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Graefe's Arch. Clin. Exp. Ophthalmol. 1994; 232: 591-8.
16. Martin P, Mauget M, Gérard JP, Chiquet C, Milea D, Koenig F, Bouret V, Sentenac I. Radiothérapie des dégénérescences maculaires liées à l'âge (DMLA) : Résultats préliminaires d'une étude lyonnaise. Cancer Radiothér. 1997; 1: 227-33.
17. Spaide R, Guyer D, Mc Cormick B, Yannuzzi L, Burke L, Mendelsohn M, Haas A, Slakter J, Sorenson J, Fisher Y, Abramson D. External beam radiation therapy for choroidal neovascularization. Ophthalmol. 1998; 105: 24-30.
18. Bergink GJ, Hoyng CB, van der Maazen RWM, Vingerling JR, van Daal WAJ, Deutman AF. A randomized controlled clinical trial on the efficacity of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefe's Arch. Clin. Exp. Ophthalmol. 1998; 236: 321-5.
19. Holz FG, Unnebrink K, Engenhart-Cabillic R, Bellman C, Pritsch M, Völker HE. Results of prospective, randomized, controled, double blind multicenter trial on external beam radiation therapy for subfoveal choroïdal neovascularization secondary to ARMD (RAD-STUDY). Invest. Ophthalmol. Vis. Sci. 1999; 40: S 402-2115.
20. Sagerman RH, Chung CT, Alberti WE. Radiosensibility of ocular and orbital structures. In : Radiotherapy of intraocular and orbital tumors. 1994; 38: 375-85. Alberti and Sagerman Ed Springer-Verlag.
21. Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Shatz NJ. Radiation optic neuropathy. Ophthalmol. 1982; 89: 1489-93.
22. Merriam GR, Szechter A, Focht EF. The effects of ionizing radiations on the eye. Front. Radiat. Ther. Oncol. 1972; 6: 346-85.
23. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int. J. Rad. One. Biol. Phys. 1995; 31(5): 1123-39.
24. Wara W, Irvien A, Neger R et al. Radiation retinopathy. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 81-3.
25. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard retinopatny. Am. J. Ophthalmol. 1991; 112: 600-1.
26. Archer DB, Amoaku WMK, Gardiner TA. Radiation retinopathy, clinical, histological, and ultrastructural correlations. Eye. 1991; 5: 239-51.
27. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Rad. 1976; 120: 167-71.
28. Parsons J, Bova F, Fitzgerald C et al. Radiation retinopathy after external beam irradiation: analysis of time dose factors. Int. J. Rad. Onc. Biol. Phys. 1994; 30: 765-73.
29. Archer DB, Gardiner TA. Ionizing radiation and the retina. Cur. Op. Ophthalmol. 1994; 5: 59-65.
30. Aristizabal S, Caldwell WL, Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int. J. Rad. Onc. Biol. Phys. 1977; 2: 667-73.
31. Hart PM, Chakravarthy U, MacKenzie G, Archer DB, Houston RF. Teletherapy for subfoveal choroidal neovascularisation of age-relatedmacular degeneration: results of follow-up in a non-randomized study. Br. J. Ophthalmol. 1996; 80: 1046-50